Abstract:Objective To investigate the expression of survivin,vascular endothelial growth factor(VEGF),and active caspase-3 in different phases of hemangiomas and analyze their relationship.Methods The samples of 15 normal controls and 45 hemangioma patients(30 proliferating and 15 involuting) were evaluated by immunohistochemistry to determine the expression of survivin,VEGF,and active caspase-3.The data were analyzed by Kuskal-Wallis H test,Mann-Whittney U test,and Spearman rank correlation.The values were considered significant at P0.05.Results(1) Survivin mainly localized in nucleus of the endothelial cell.Its positive rates were 80%(24/30) in proliferating hemangioma,60%(9/15) in involuting hemangioma,and 0(0/15),in normal tissue.The difference between proliferating and involuting hemangioma was statistically significant(P0.05),and their differences between the hemangioma groups and normal control group were also significant(P0.01).(2) VEGF mainly expressed in cytoplasm and membrane of the endothelial cell.Its positive rate was 90%(27/30) in proliferative hemangiomas,46.7%(7/15) in involuting hemangiomas,and 0(0/15) in normal tissues.The differences between the groups were statistically significant(P0.01).(3) Active caspase-3 mainly located in nucleus of the endothelial cell.Its positive rates were 60%(18/30) in proliferative phase,86.7%(13/15) in involuting phase,and 0(0/15) in normal tissue.The difference between proliferating and involuting hemangiomas was statistically significant(P0.05),and the differences between the hemangioma groups and normal control group were also statistically significant(P0.01).(4) VEGF in hemangioma showed positive correlation with survivin(r=0.54,P0.01),while active caspase-3 showed negative correlation with survivin(r=-0.51,P0.01).Conclusion Inhibition of caspase-3 by VEGF/survivin may play a key role in the conversion from proliferating hemangioma to involuting hemangioma.Molecular intervention in the inhibitory path may provide a new strategy for the management of hemangiomas and angiogenesis-dependent diseases.

The Expression of Proliferating Cell Nuclear Antigen in Hernangioma and Its Significance

[Expression of Proliferating Cell Nuclear Antigen in Hemangioma and Vascular Malformations].

Expression of Proliferating Cell Nuclear Antigen in Wiims'Tumor

Relationship Between Expression of Proliferating Cell Nuclear Antigen and Prognosis of Colorectal Cancer

Expression and Significance of PCNA Protein and MVD in Pancreatic Adenocarcinoma

Expression of Proliferating Cell Nuclear Antigen in Non-Hodgkin's Lymphoma

Expressions of Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Hemangioma

Expression of Angiopoietin-1,Angiopoietin-2 and Tie2 in Proliferative Hemangioma

Research on Expression and Correlation of Survivin,Vascular Endothelial Growth Factor,and Active Caspase-3 in Different Phases of Hemangiomas

The Expression and Significance of Telomerase Reverse Transcriptase(TERT) in Infantile Hemangiomas

Expression of Hypoxia Inducible Factor-1Α, 3α in Hemangioma

The Expressions of Survivin and Bax in Hemangioma

Evaluation of Prognosis and Expression of PCNA in the Early Breast Cancer

[The Study of Expression and Distribution of PCNA in Hypertrophic Scar Tissue].

The Study on Effect of Apoptosis-related Gene C-myc, Bcl-2 and P53 in Infancy Hemangiomas

STUDY ON THE EXPRESSION OF PCNA IN GESTATIONAL TROPHOBLASTIC TUMOR

Detection of Proliferation Activity in Neuroblastomas and Its Clinical Significance

Expression of Survivin and TRAIL in Hemangioma

[Indentification of Differentially Expressed Genes in Proliferating and Involuting Hemangiomas by Cdan Microarray Analysis of Gene-Expression Profiles].

[Expression of Cellular Adhesion Molecules and HLA-DR Antigen on Vascular Endothelial Cells in Hemangiomas.].

[The Characteristics of PCNA Expression in Hypertrophic Scars and Chronic Ulcers and Implication of the Expression].